| CTRI Number |
CTRI/2024/05/067165 [Registered on: 10/05/2024] Trial Registered Prospectively |
| Last Modified On: |
09/05/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug |
| Study Design |
Randomized, Parallel Group Trial |
|
Public Title of Study
|
A study compares the effects of Dexmedetomidine administered via trachea versus vein on recovery process and peri-extubation cough prevention. Patients and evaluators remain unaware of treatment assignment |
|
Scientific Title of Study
|
Comparison of effect of low dose intratracheal and intravenous dexmedetomidine administration on recovery from general anaesthesia after abdominal surgery: a randomised double blinded study |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Chanda Khatri |
| Designation |
Professor |
| Affiliation |
Dr S N Medical college |
| Address |
Janana Wing, Dr. S N Medical College, Department of Anaesthesiology, Sector D, Shastri Nagar, Jodhpur, Rajasthan
Jodhpur RAJASTHAN 342003 India |
| Phone |
88619236716 |
| Fax |
|
| Email |
chandakhatri90@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Piyush Nawal |
| Designation |
PG Student |
| Affiliation |
Dr S N Medical college |
| Address |
Janana Wing, Dr. S N Medical College, Department of Anaesthesiology, Sector D, Shastri Nagar, Jodhpur, Rajasthan.
Jodhpur RAJASTHAN 342003 India |
| Phone |
9518739860 |
| Fax |
|
| Email |
piyushnawal30@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Piyush Nawal |
| Designation |
PG STUDENT |
| Affiliation |
Dr S N Medical college |
| Address |
Janana Wing, Dr. S N Medical College, Department of Anaesthesiology, Sector D, Shastri Nagar, Jodhpur, Rajasthan
Jodhpur RAJASTHAN 342003 India |
| Phone |
9518739860 |
| Fax |
|
| Email |
piyushnawal30@gmail.com |
|
|
Source of Monetary or Material Support
|
| Dr S N Medical College, Department of Anesthesiology
|
|
|
Primary Sponsor
|
| Name |
Dr S N Medical college |
| Address |
Dr. S N Medical College, Department of Anaesthesiology, Sector D, Shastri Nagar, Jodhpur, Rajasthan |
| Type of Sponsor |
Government medical college |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Piyush Nawal |
DR S N MEDICAL COLLEGE |
Department of Anaesthesiology, Main OT, A-5, near Central Laboratory, Sector H, Shastri Nagar, Jodhpur, Rajasthan. Jodhpur RAJASTHAN |
9518739860
piyushnawal30@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Dr SNMC INSTITUTIONAL ETHICS COMMITTEE |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: K800||Calculus of gallbladder with acutecholecystitis, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Intratracheal dexmedetomidine |
The medications tagged with the study group, administered intratracheally half hour before the end of the surgery Dex (0.3mcg/kg, diluted and mixed in 2mL saline) will be sprayed down the intratracheal tube of patients in the DT group with needle of 5 ml syringe followed by positive breath, total duration of intervention will be from half hour before end of surgery to half hour post extubation |
| Comparator Agent |
Intravenous dexmedetomidine |
The patients in the DV group will be intravenously given the same dose of Dexmedetomidine (0.3mcg/kg diluted in 20 ml NS) 15 minutes prior to the end of surgery as an infusion over 10 min, total duration of intervention will be from fifteen minutes before end of surgery to half hour post extubation |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
Individuals of both genders aged between 18 and 60 years, with a weight falling within the range of 40 to 80 kg with physical status American Society of Anaesthesiologists (ASA) I and II, undergoing elective abdominal surgery under general anaesthesia will be included. |
|
| ExclusionCriteria |
| Details |
1) Long term use of sedative drugs (benzodiazepines, barbiturates),
2) Anticipated difficult airway,
3) Those who received alpha2 agonists preoperatively,
4) Patients who were transferred to open surgery during the operation were excluded from the final analysis. |
|
|
Method of Generating Random Sequence
|
Computer generated randomization |
|
Method of Concealment
|
Sequentially numbered, sealed, opaque envelopes |
|
Blinding/Masking
|
Participant and Outcome Assessor Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| The primary outcome will include severity of cough at extubation assessed by 4 point cough scale |
0 minutes, 2 minutes, 5 minutes, 15 minutes, 30 minutes post extubation |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Monitoring of hemodynamic parameters |
5 min before anaesthesia(T0), immediately after administration of dexmedetomidine(T1), 5 min after DEXMEDETOMIDINE(T2), 10 min after DEXMEDETOMIDINE(T3), at end of surgery(T4), at awareness(T5), at extubation(T6), 2 min after extubation(T7), 5 min after extubation(T8), 15 min after extubation(T9), 30 min after extubation(T10) |
|
|
Target Sample Size
|
Total Sample Size="90" Sample Size from India="90"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
Phase 3/ Phase 4 |
|
Date of First Enrollment (India)
|
20/05/2024 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="0" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - YES
- What data in particular will be shared?
Response - Individual participant data that underlie the results reported in this article, after de-identification (text, tables, figures, and appendices).
- What additional supporting information will be shared?
Response - Study Protocol
- Who will be able to view these files?
Response - Researchers whose proposed use of the data has been approved by an independent review committee identified for this purpose.
- For what types of analyses will this data be available?
Response - For individual participant data meta-analysis.
- By what mechanism will data be made available?
Response - Proposals should be directed to [PIYUSHNAWAL30@GMAIL.COM].
- For how long will this data be available start date provided 30-12-2024 and end date provided 30-12-2029?
Response - Beginning 3 months and ending 5 years following article publication.
- Any URL or additional information regarding plan/policy for sharing IPD?
Additional Information - NIL
|
|
Brief Summary
|
Emergence from general anaesthesia can result in a number of undesirable side effects including cough, hypertension, tachycardia, and agitation. These side effects may cause haemorrhage from the surgical wound site and also increase the in intraocular and intracranial pressures. Dexmedetomidine emerges as a potent alpha-2-selective adrenoceptor agonist, inducing sympatholysis, sedation, and analgesia without compromising respiratory function. The instillation of local anesthetics and dexmedetomidine directly into the trachea emerges as a promising strategy to counter laryngeal reflexes, gaining credibility in real-world clinical practices. Hence our aim is to compare the efficacy of Intratracheal dexmedetomidine (Dex) vs Intravenous dexmedetomidine injection for recovery from general anaesthesia following abdominal surgery. |